AIN/Sandipan Shringi
LightNews LightNews
nephrosage.bsky.social
AIN/Sandipan Shringi
@nephrosage.bsky.social
120 followers 770 following 51 posts
AnotherIndianNephrologist @Nephrosage
Posts Replies Media Videos
nephrosage.bsky.social
Individualizing renoprotective therapy in obesity and CKD: a commentary by the Diabesity Working Group of the ERA
More info: academic.oup.com/ndt/article/...
@ndt-era.bsky.social, @hjanders.bsky.social
October 16, 2025 at 4:31 PM
nephrosage.bsky.social
Treatment of relapsing minimal change podocytopathy
More info: academic.oup.com/ndt/article-...
@ndt-era.bsky.social, @hjanders.bsky.social
October 15, 2025 at 2:08 PM
nephrosage.bsky.social
Cardio-kidney outcomes for combined versus monotherapy with finerenone or SGLT2 inhibitors in patients with CKD
More info: academic.oup.com/ndt/article/...
@ndt-era.bsky.social, @hjanders.bsky.social
October 14, 2025 at 1:16 PM
nephrosage.bsky.social
EKFC or CKD-EPIASR-NB2009 formula. Which equation to use?
More info: academic.oup.com/ndt/article/...
@ndt-era.bsky.social, @hjanders.bsky.social
October 10, 2025 at 12:08 PM
nephrosage.bsky.social
Dietary vitamin E and tocopherol isoform intake and the progression of CKD
More info: academic.oup.com/ndt/article-...
@ndt-era.bsky.social, @hjanders.bsky.social
October 9, 2025 at 4:30 PM
nephrosage.bsky.social
Acute post-streptococcal glomerulonephritis in children—treatment standard
More info: academic.oup.com/ndt/article/...
@ndt-era.bsky.social, @hjanders.bsky.social
October 8, 2025 at 2:08 PM
nephrosage.bsky.social
SGLT2 inhibitors in CKD: are they really effective in all patients?
More info: academic.oup.com/ndt/article/...
@ndt-era.bsky.social, @hjanders.bsky.social
October 7, 2025 at 1:15 PM
nephrosage.bsky.social
Review on Renal amyloidosis
More info: academic.oup.com/ndt/article-...
@ndt-era.bsky.social, @hjanders.bsky.social
October 6, 2025 at 3:34 PM
nephrosage.bsky.social
More on IgAN
More info: academic.oup.com/ndt/article/...
@ndt-era.bsky.social, @hjanders.bsky.social
October 2, 2025 at 4:30 PM
nephrosage.bsky.social
Acute kidney injury, acute kidney disease and chronic kidney disease: challenges and research perspectives
More info: academic.oup.com/ndt/article/...
@ndt-era.bsky.social, @hjanders.bsky.social
September 4, 2025 at 7:10 PM
nephrosage.bsky.social
A step toward personalized medicine
More info: academic.oup.com/ndt/article/...
@ndt-era.bsky.social, @hjanders.bsky.social, @Richard Glassock, @Andrew Rule, @Aleksandar Denic, @delanaye.bsky.social
September 3, 2025 at 10:20 PM
nephrosage.bsky.social
Key efforts to leave those 20-30 nephrons where they belong..in the kidney! Can biopsy be prevented using PLA2R in the select few?
More info: academic.oup.com/ndt/article/...
@ndt-era.bsky.social, @hjanders.bsky.social
September 3, 2025 at 8:59 PM
nephrosage.bsky.social
Antibody-mediated rejection—treatment standard
More info: academic.oup.com/ndt/article/...
@ndt-era.bsky.social, @hjanders.bsky.social
August 8, 2025 at 3:32 PM
nephrosage.bsky.social
HDF over HD: New report from the EuDial working group
More info: academic.oup.com/ndt/article/...
@ndt-era.bsky.social, @hjanders.bsky.social
August 8, 2025 at 12:08 PM
nephrosage.bsky.social
More RBC casts in a case of IgAN? might mean treatable and reversible
More info: academic.oup.com/ndt/article/...
Image courtesy: @RenalFellowNtwk/X
@ndt-era.bsky.social, @hjanders.bsky.social
August 7, 2025 at 7:10 PM
nephrosage.bsky.social
CONFIDENCE trial: You know the population; now we await the results...
More info: academic.oup.com/ndt/article/...
@ndt-era.bsky.social, @hjanders.bsky.social
August 7, 2025 at 4:30 PM
nephrosage.bsky.social
Deafness and dRTA: ATP6V1B1 mutation affecting H+-ATPase structure
More info: academic.oup.com/ndt/article/...
@ndt-era.bsky.social, @hjanders.bsky.social
August 6, 2025 at 10:20 PM
nephrosage.bsky.social
Another treatment-related cause of AKI to remember: Teclistamab, a bispecific monoclonal antibody targeting CD3 and B cell maturation antigen, used for relapsing/refractory MM
More info: academic.oup.com/ndt/article/...
#onconephrology
@ndt-era.bsky.social, @hjanders.bsky.social
August 6, 2025 at 2:08 PM
nephrosage.bsky.social
CKD and inflammation: Use of vagal nerve stimulation as a potential therapeutic target.
More info: academic.oup.com/ndt/article/...
@ndt-era.bsky.social, @hjanders.bsky.social
August 5, 2025 at 8:19 PM
nephrosage.bsky.social
Can AI help reduce the carbon footprint of nephrology? Some thoughts...
More info: academic.oup.com/ndt/article/...
@ndt-era.bsky.social, @hjanders.bsky.social
August 4, 2025 at 7:08 PM
nephrosage.bsky.social
The new Ritux? Obinutuzumab is the new trend in glomerular diseases
More info: academic.oup.com/ndt/advance-...
@ndt-era.bsky.social, @hjanders.bsky.social
August 4, 2025 at 3:34 PM
nephrosage.bsky.social
daprodustat daily or epoetin alfa in PD patent
More info: academic.oup.com/ndt/article/...
@ndt-era.bsky.social, @hjanders.bsky.social
August 1, 2025 at 12:08 PM
nephrosage.bsky.social
Prescribing low K diet in all CKD patients?
More info: academic.oup.com/ndt/article/...
@ndt-era.bsky.social, @hjanders.bsky.social
July 31, 2025 at 5:32 PM
nephrosage.bsky.social
Does having multiple kidney cysts put you in Alpert's spectra?
More info: academic.oup.com/ndt/article-...
@ndt-era.bsky.social, @hjanders.bsky.social
July 30, 2025 at 1:45 PM
nephrosage.bsky.social
In-depth review on optimizing steroid use in Lupus nephritis.
More info: academic.oup.com/ndt/article/...
@ndt-era.bsky.social, @hjanders.bsky.social
July 29, 2025 at 5:32 PM